DeepVerge plc
DVRG.L
London Stock Exchange0.15
GBp
+0.00
- -
DeepVerge plc
DVRG.L
(London Stock Exchange)
Recent
price
0.15
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- DeepVerge plc (DVRG.L), an Ireland-headquartered environmental and life sciences company founded in 2016, develops and applies artificial intelligence and Internet of Things technologies to analytical instruments for the detection and identification of bacteria, viruses, and toxins in sectors including cosmetics, pharmaceuticals, water management, and personal care. The company offers core products and services such as Labskin, a commercially available lab-grown full-thickness human skin model with an AI-assisted testing platform for product research and regulatory validation in cosmetics, medical devices, and pharmaceuticals; Rinocloud, a data infrastructure-as-a-service platform providing secure intelligent storage, sharing, search capabilities, encryption, and AI technologies; Skin Trust Club, a consumer skin health tracking service utilizing advanced sequencing, bioinformatics, and AI algorithms; Modern Water technologies encompassing bioluminescence, voltammetry, immunoassay systems, and real-time pathogen detection platforms like Microtox PD for monitoring wastewater treatment plants, drinking water, rivers, lakes, and reservoirs; regulated environmental toxicology services; AI and microbiome platforms supporting clinical trials and remote test-kits for skincare; and a range of skincare products and cannabinoid oils. DeepVerge operates in the United Kingdom, Europe, the United States, India, and internationally, serving clients including top global cosmetic companies, utilities, and local authorities. Formerly known as Integumen Plc until its rebranding in October 2020, the company underwent significant changes including the 2022 acquisition of engineering firm Glanaco for £1.08 million to in-house Microtox PD assembly and secure a £25 million mezzanine loan facility for expansion; a 2023 sale of Glanaco back to its prior owners; an exclusivity agreement leading to the 2024 divestiture of its Modern Water assets and Microtox business to Microsaic Systems; exploration of options for its Labskin division; a £10 million share placing; and entry into liquidation proceedings in September 2024 with its registered office relocated to Gateshead, UK.